US Patent Issued to LANOVA MEDICINES on July 28 for "Anti-4-1BB nanobodies" (Chinese Inventors)

ALEXANDRIA, Va., July 28 -- United States Patent no. 12,692,318, issued on July 28, was assigned to LANOVA MEDICINES Ltd. (Shanghai).

"Anti-4-1BB nanobodies" was invented by Runsheng Li (Shanghai) and Wentao Huang (Shanghai).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided are anti-4-1BB nanobodies and bispecific or multispecific antibodies that incorporate the nanobodies. Methods of using the antibodies for treating and diagnosing diseases such as cancer are also provided."

The patent was filed on May 2, 2025, under Application No. 19/197,775.

*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetaht...